Wagner Macula & Retina Center | Norfolk, VA

Research site
6160 Kempsville Circle, Norfolk, Virginia, United States of America
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


3 of 16
Status: Active
Trial type: Interventional
Funder type: Industry

A Clinical Trial on Safety and Efficacy of CBT-001 in Patients With Pterygium

The objective is to evaluate the safety and efficacy of low dose and high dose CBT-001 eye drop dosed twice daily for 24 months compared to vehicle i...

Drug: Vehicle
Drug: CBT-001

This main long-term extension study is designed to evaluate the long-term safety and tolerability of faricimab 6 milligrams (mg) administered by intr...

Active, not recruiting
Neovascular Age-related Macular Degeneration
Other: Sham Procedure
Drug: Faricimab

RGX-314 is being developed as a novel one-time gene therapy for the treatment of neovascular (wet) age-related macular degeneration (wet AMD). Wet AM...

Wet Age-related Macular Degeneration
Genetic: RGX-314 Dose 2
Biological: Aflibercept (EYLEA®)

Trial conditions

Macular Degeneration (8 trials)
Edema (4 trials)
Macular Edema (4 trials)
Atrophy (3 trials)
Geographic Atrophy (3 trials)
Wet Macular Degeneration (3 trials)
Diabetic Retinopathy (1 trial)
Pterygium (1 trial)

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems